Related Experiment Video

Updated: Aug 7, 2026

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting
10:08

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting

Published on: December 9, 2022

Structure of human Fyn kinase domain complexed with staurosporine

Takayoshi Kinoshita1, Mamoru Matsubara, Hiroshi Ishiguro

  • 1Department of Biological Science, Graduate School of Science, Osaka Prefecture University, Gakuencho 1-1, Sakai, Osaka 599-8531, Japan. kinotk@b.s.osakafu-u.ac.jp

Biochemical and Biophysical Research Communications
|June 20, 2006
PubMed

Insights

Inhibiting Fyn kinase, implicated in neurodegenerative diseases like Alzheimer's, may offer therapeutic benefits. Crystal structure analysis reveals how inhibitors bind, aiding the development of selective drugs for nervous system disorders.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Structural Biology

Background:

  • Fyn is a tyrosine kinase in the Src family, crucial for T cell signaling.
  • Excess Fyn activity in the brain is linked to Alzheimer's and Parkinson's diseases.
  • Targeting Fyn kinase presents a potential therapeutic strategy for neurological disorders.

Purpose of the Study:

  • To elucidate the structural basis of Fyn kinase inhibition.
  • To investigate the binding of staurosporine to the human Fyn kinase domain.
  • To identify structural features that could enable selective Fyn kinase inhibition.

Main Methods:

  • X-ray crystallography was used to determine the structure of the human Fyn kinase domain.
  • The crystal structure was solved at 2.8 Å resolution.
  • The complex of Fyn kinase with the inhibitor staurosporine was analyzed.

Main Results:

  • The crystal structure of the human Fyn kinase domain complexed with staurosporine was determined.
  • Staurosporine occupies the ATP-binding site of Fyn, similar to its binding in Lck and Csk.
  • Subtle structural variations exist in the inhibitor-binding regions of Fyn, Lck, and Csk.

Conclusions:

  • Understanding Fyn kinase structure provides insights into its role in neurological diseases.
  • The structural data can guide the design of selective Fyn kinase inhibitors.
  • Targeting Fyn kinase may offer a novel therapeutic approach for Alzheimer's and Parkinson's diseases.

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells06:29

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells

Published on: July 30, 2020

Related Concept Videos

Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
ATP Synthase: Structure01:18

ATP Synthase: Structure

ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...